Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-000806
Filing Date
2025-01-07
Accepted
2025-01-07 21:28:08
Documents
1
Period of Report
2025-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736303281.html 4  
1 FORM 4 wk-form4_1736303281.xml 4 9981
  Complete submission text file 0001628280-25-000806.txt   11721
Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Issuer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 225 S. LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address
O'Brien Patrick (Reporting) CIK: 0001627183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38042 | Film No.: 25516385